Latest filings (excl ownership)
15-12B
Securities registration termination
11 Feb 20
8-K
Other Events
11 Feb 20
8-K
Monthly Operating Report
10 Feb 20
8-K
Entry into a Material Definitive Agreement
5 Feb 20
8-K
Regulation FD Disclosure
17 Jan 20
8-K
Regulation FD Disclosure
10 Jan 20
8-K
Entry into a Material Definitive Agreement
6 Jan 20
S-8 POS
Registration of securities for employees (post-effective amendment)
3 Jan 20
S-8 POS
Registration of securities for employees (post-effective amendment)
3 Jan 20
S-8 POS
Registration of securities for employees (post-effective amendment)
3 Jan 20
S-8 POS
Registration of securities for employees (post-effective amendment)
3 Jan 20
S-8 POS
Registration of securities for employees (post-effective amendment)
3 Jan 20
8-K
Monthly Operating Report
26 Dec 19
8-K
Entry into a Material Definitive Agreement
3 Dec 19
NT 10-Q
Notice of late quarterly filing
25 Nov 19
8-K
Regulation FD Disclosure
20 Nov 19
8-K
Monthly Operating Report
4 Nov 19
8-K
Entry into a Material Definitive Agreement
25 Oct 19
8-K
Monthly Operating Report
2 Oct 19
8-K
Completion of Acquisition or Disposition of Assets
27 Sep 19
8-K
Entry into a Material Definitive Agreement
26 Sep 19
8-K
Regulation FD Disclosure
17 Sep 19
8-K
Monthly Operating Report
9 Sep 19
8-K
Entry into a Material Definitive Agreement
3 Sep 19
8-K
Other Events
29 Aug 19
8-K
Monthly Operating Report
13 Aug 19
NT 10-Q
Notice of late quarterly filing
8 Aug 19
8-K
Entry into a Material Definitive Agreement
8 Aug 19
8-K
In the United States Bankruptcy Court for the District of Delaware
19 Jul 19
8-K
Departure of Directors or Certain Officers
15 Jul 19
25-NSE
Exchange delisting
24 Jun 19
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
11 Jun 19
8-K
Bankruptcy or Receivership
10 Jun 19
8-K/A
Departure of Directors or Certain Officers
7 Jun 19
8-K
Departure of Directors or Certain Officers
5 Jun 19
8-K
Departure of Directors or Certain Officers
24 May 19
10-Q
2019 Q1
Quarterly report
13 May 19
8-K
INSYS Therapeutics Reports First Quarter 2019 Results
13 May 19
NT 10-Q
Notice of late quarterly filing
10 May 19
10-K/A
2018 FY
Annual report (amended)
30 Apr 19
Latest ownership filings
SC 13G
Insys Therapeutics, Inc.
19 Nov 19
4
Andrece Housley
6 Jun 19
3
Andrece Housley
6 Jun 19
4
Andrew G Long
5 Jun 19
SC 13G/A
Insys Therapeutics, Inc.
29 Apr 19
4
ELIZABETH BOHLEN
23 Apr 19
4
Vaseem Mahboob
23 Apr 19
4
Mark E Nance
23 Apr 19
4
Geertrui Vanhove
23 Apr 19
3
Geertrui Vanhove
23 Apr 19
4
Saeed Motahari
23 Apr 19
4
Andrew G Long
23 Apr 19
4
STEVEN J MEYER
23 Apr 19
4
PIERRE LAPALME
23 Apr 19
4
Rohit Vishnoi
23 Apr 19
4
Rohit Vishnoi
19 Apr 19
4
Andrew G Long
19 Apr 19
4
Saeed Motahari
19 Apr 19
4
Mark E Nance
19 Apr 19
4
Vaseem Mahboob
19 Apr 19
4
ELIZABETH BOHLEN
19 Apr 19
4
PIERRE LAPALME
19 Apr 19
4
STEVEN J MEYER
19 Apr 19
4
Geertrui Vanhove
19 Apr 19
3
Geertrui Vanhove
19 Apr 19
SC 13G/A
Insys Therapeutics, Inc.
7 Mar 19
SC 13G/A
Insys Therapeutics, Inc.
26 Feb 19
SC 13G
Insys Therapeutics, Inc.
19 Feb 19
SC 13G/A
Insys Therapeutics, Inc.
13 Feb 19
4
Mark E Nance
12 Oct 18
3
Mark E Nance
12 Oct 18
4
ELIZABETH BOHLEN
9 Aug 18
3
ELIZABETH BOHLEN
9 Aug 18
4
Andrew G Long
7 Aug 18
4
Brian Tambi
14 May 18
4
Rohit Vishnoi
10 May 18
4
PIERRE LAPALME
10 May 18
4
STEVEN J MEYER
10 May 18
4
Saeed Motahari
17 Apr 18
3
Initial statement of insider ownership
8 Mar 18